ADVERTISEMENT
image

Welcome to the Anticoagulation Resource Center

Supported by an unrestricted grant from the Bristol Myers Squibb/Pfizer Alliance.

BMS Logo Pfizer Logo
This resource center offers pharmacists essential information on:
  • Anticoagulation guidelines
  • Clinical considerations
  • Anticoagulation stewardship
  • Billing and reimbursement
  • Helping patients make informed decisions about healthcare options
Anticoagulation
Resources From The Anticoagulation Forum
Additional Resources

Resources from APhA

Clinical considerations: Anticoagulation use in older adults

Anticoagulation therapy in older adults requires careful consideration due to age-related changes in physiology, increased risk of comorbidities, and higher susceptibility to adverse drug reactions. This resource highlights facts and clinical considerations related to use of anticoagulants in older adults.

Download Now

Show You Know: Anticoagulation in the older adult

Current evidence indicates that 20% to 50% of direct oral anticoagulant doses are inappropriate in older adults. Over- and underdosing of anticoagulants in the older adult population can lead to adverse effects and increased risk of stroke, systemic embolism, and cardiovascular hospitalizations. Take this short quiz to assess your skill related to best practices of use of anticoagulants in older adults.

Take the quiz

The Journey to Atrial Fibrillation Management: A Patient Perspective

Atrial fibrillation is the most common type of irregular heartbeat, affecting more than 5 million adults in the United States and it is estimated that 12.1 million people in the United States will experience atrial fibrillation in 2030.Atrial fibrillation is the most common type of irregular heartbeat, affecting more than 5 million adults in the United States and it is estimated that 12.1 million people in the United States will develop atrial fibrillation in 2030. This course includes 3 modules that features a patient's perspective during their journey with atrial fibrillation. Supported by an educational grant from Bristol-Myers Squibb-Pfizer Alliance.

Access The Course

What’s on tap: 2023 Beers Criteria Update

In 1991, Mark Beers, MD, and colleagues at University of California Los Angeles developed the Beers Criteria to identify potentially inappropriate medication (PIM) for nursing home residents.1 Since their initial release, the Beers Criteria has been updated six times and expanded the criteria to apply to all adults 65 years and older

Download Now

Solutions for Atrial Fibrillation Edvocacy (SAFE) - APhA Foundation

Solutions for Atrial Fibrillation Edvocacy (SAFE) was a research project focused on leveraging community pharmacies for Afib screening, detection, and referral to physicians for follow-up and initiation of evidence-based therapy when appropriate. This prospective research study was conducted with 14 community pharmacies across the US, in which a total of 650 patients were screened for Afib. Pharmacists conducted SAFEty Risk Assessments that consisted of completion of a Stroke Risk Scorecard and EKG determination utilizing AliveCor’s KardiaMobile® 6L device.

Download Now
Advertisement
Advertisement
ADVERTISEMENT